Spirulina and Chlorella — Body Handbook

Supplements · §524

Spirulina and Chlorella

You've seen spirulina sold as a green protein-detox-energy-immune-B12 cure-all — about eighty percent of that is marketing, but the twenty percent left over is real, modest, and worth knowing. Two pond-grown microalgae — spirulina, a blue-green cyanobacterium, and chlorella, a true green alga — taken as tablets for a couple of months can nudge cholesterol and blood pressure down a few points, and lift hemoglobin if you were short on iron. The catch is contamination: a meaningful slice of cheap product carries lead, mercury, or liver-toxic cyanobacterial chemicals above legal limits, so the brand you buy matters more than whether you take it at all.

Do · Daily Evidence Mixed Chapter Supplements

At a real dose — five to eight grams a day, ten to sixteen tablets — three months of either algae moves a typical lipid panel and blood pressure a few points in the right direction; if your iron was low, hemoglobin rises in a way you'd actually feel. Most people who take "a few tablets" never see anything happen because they're at a fraction of the studied dose. None of this is a one-substance transformation; it's a small adjunct for a few specific situations. The decision that matters is sourcing — buy from a brand with third-party heavy-metal and cyanotoxin testing, or skip it; the cheap bulk powder is where the real risk lives.

Spirulina is a cyanobacterium — strictly speaking, an ancient kind of bacteria that photosynthesises like a plant. Chlorella is a single-celled green alga, more like a tiny floating plant. Both grow in warm freshwater ponds and get dried into the powder or pressed into the tablets you see in supplement aisles.

The active ingredient most often credited for spirulina's effects is phycocyanin, the blue chromoprotein that gives it its colour — somewhere between a tenth and a fifth of its dry weight. Phycocyanin chemistry resembles a molecule your liver makes naturally (biliverdin), and it quiets an enzyme called NADPH oxidase that pumps out vascular wear-and-tear chemicals. That's the leading explanation for spirulina's small blood-pressure effect Machowiec et al. 2021. The cholesterol effect is harder to pin down — phycocyanin plus an oil called γ-linolenic acid, plus some direct blocking of cholesterol absorption in the gut Karkos et al. 2011.

Chlorella's story is messier but useful. Chlorophyll, omega-3 fats, carotenoids, plant-form iron — and, uniquely among the algae sold as B₁₂ sources, a small amount of the real, bioactive form of vitamin B₁₂ called methylcobalamin Kumudha et al. 2015, Bito et al. 2020. Its rigid cellulose cell wall binds heavy metals, the trait behind its decades-old reputation as a "detox" supplement; the cell wall is also why cheap intact-cell chlorella barely absorbs — look for "broken" or "cracked" cell wall on the label.

The iron in both is plant-form iron — the same kind you get from spinach. Not as well-absorbed as iron from meat, but real, and enough to matter when you were running short.

What actually happens at supplement doses

Three answers — and one of them is "less than the marketing says".

For cholesterol and blood pressure, the direction is real and the size is small. Take spirulina at five to eight grams a day for two to three months, and a typical lipid panel moves a few mg/dL — total cholesterol and LDL both drift down, triglycerides too. Blood pressure does the same on the order of a few mmHg systolic. Chlorella shows the same shape, smaller magnitude. None of this competes with a statin or with losing ten pounds; all of it is a modest nudge on top of whatever else you were doing.

For iron, the effect is sharper but narrower. Anemic Mexican seniors taking three grams of spirulina daily for twelve weeks raised their hemoglobin by about 1.2 g/dL — the kind of rise you feel as "I'm not winded climbing the stairs anymore" Selmi et al. 2011. Japanese pregnant women taking six grams of chlorella through the second half of pregnancy had less anemia, less protein in their urine, and less swelling than unsupplemented controls Nakano et al. 2010. If your iron was fine to start, neither algae adds anything you'd notice. If it wasn't, both deliver real iron at a real, if low, absorption rate.

Antioxidant blood markers also shift — the enzymes that mop up oxidative damage rise, the markers of that damage fall, on doses of four to eight grams a day for a couple of months Karkos et al. 2011. Whether any of that translates into something you can see in the mirror or a lower disease risk a decade out is unproven; it's the kind of biomarker shift that often, but not always, tracks long-term cardiovascular benefit.

And the most-repeated claim — that spirulina solves vegan B₁₂ — is wrong. The "B₁₂" in spirulina is mostly a near-look-alike molecule called pseudovitamin B₁₂: it shows up on blood assays as if it were the real thing, but your enzymes can't use it — meaning your actual B₁₂ status can quietly worsen while your blood test looks reassuring Watanabe et al. 1999, Watanabe 2007. Chlorella does carry real methylcobalamin in small amounts. If you're vegan and serious about B₁₂, take a B₁₂ tablet; treat chlorella as a hedge, not a strategy.

What the back of the jar gets wrong

Three myths repeat across every label.

"Vegan B₁₂ source." Not for spirulina. About eighty-three percent of spirulina's B₁₂-shaped molecule is the inactive pseudovitamin form, and there are case reports of vegans developing functional B₁₂ deficiency while loyally taking it Watanabe et al. 1999, Watanabe 2007. A real B₁₂ tablet costs a few dollars a year and solves the problem; spirulina does not.

"Complete-protein superfood." Spirulina is roughly sixty percent protein by weight — true — but a typical 3 g supplement dose delivers about 1.8 grams of protein, against a daily need of fifty to a hundred. The protein argument only works at famine-relief doses (ten-plus grams), not at supplement doses. A boiled egg has three times the usable protein and costs less.

"Detox heavy metals." Chlorella binds methylmercury in rats and famously helped speed clearance of dioxins after a major Japanese rice-oil poisoning, but no human trial in non-poisoned adults has shown it actually drops your measured body-burden of metals Uchikawa et al. 2010, Bito et al. 2020. The bitter irony is that the algae themselves are one of the most common ways casual buyers take on heavy-metal exposure they didn't have before.

If you do take it

The trials that found real effects used spirulina at five to eight grams a day and chlorella at three to six grams. At the typical 500 mg tablet size, that's ten to sixteen tablets daily, split across meals — far more than the two-a-day ritual most people assume. Underdosing is the single biggest reason people conclude "it didn't work."

The bag matters more than the dose

The substance-level risk is what's in the bag, not how much of it you take. Spirulina and chlorella grow in open ponds; whatever is in the water gets into the algae and concentrated. A 2024 review of nearly ninety published heavy-metal screens found roughly ten to thirty percent of microalgal supplements over European Union limits for lead, arsenic, mercury, or cadmium, with the worst offenders being unbranded bulk product from undocumented suppliers Di Santis et al. 2024. A Quebec survey of eighteen spirulina supplements found about one in nine over the daily-tolerable limit for microcystins — a liver-toxic chemical that wild cyanobacteria sometimes produce — and detectable traces of a possible neurotoxin called BMAA in nearly all of them Roy-Lachapelle et al. 2017.

Two more common errors. People take a fraction of the studied dose — two tablets a day, occasionally — and conclude it does nothing. It probably did nothing; the data is for ten-plus tablets a day for two months. And people start dosing it heavily without checking their iron status first: if you weren't deficient, the iron does nothing useful, and if you have undiagnosed iron overload it adds to a problem you didn't know you had.

Cost is the easy part. A quality, third-party-tested 3–6 g/day regimen runs fifteen to forty dollars a month; the wellness-branded greens-powder version with the same algae inside it runs four to five times that without any extra testing.

When not to

A few conditions push the risk-benefit balance into skip-it territory.

What else does the same job

For each thing spirulina or chlorella does at the margin, there's usually a cheaper, better-evidenced option:

Lower your LDL — psyllium husk fibre at five to ten grams a day and oats both have stronger trial bases, at lower cost, with no contamination risk
Lower your blood pressure — dietary potassium, regular exercise, beetroot juice, and DASH-style eating each move the needle further
Get more iron — meat if you eat it; vitamin-C-paired lentils, beans, fortified cereals, or an iron-bisglycinate tablet (gentler on the gut than ferrous sulfate) if you don't
Get your B₁₂ — methylcobalamin or cyanocobalamin tablets; a 1000 mcg tablet two or three times a week covers nearly everyone on a plant-heavy diet
Antioxidant nudges — coloured fruit, leafy greens, green tea, and turmeric give you the same biomarker shifts in real food

Spirulina and chlorella aren't worse than these options for any of those endpoints — they're just rarely a first pick. The case for taking them is mostly that you're already plant-leaning, you like the idea of a one-tablet shave on several markers at once, and you're willing to pay for a verified-clean brand.

Related worth a look

If this was useful, the adjacent topics worth a look: how plant-based diets actually cover B₁₂ and iron over years rather than weeks; what cyanotoxin exposure means for long-term liver and brain health; how the broader supplement industry's contamination problem plays out across third-party-tested products versus unbranded bulk; and dietary nitrate (beetroot, leafy greens) as a more proven lever on blood pressure than any algae.

Substance + claimed effects

Spirulina (Arthrospira platensis, A. maxima) and chlorella (Chlorella vulgaris, C. pyrenoidosa) are edible freshwater microalgae sold as dried powder, tablets, or capsules. Spirulina is a cyanobacterium (filamentous, helical, blue-green from phycocyanin); chlorella is a true single-celled green eukaryote, rich in chlorophyll. Both are roughly 50–70% protein by dry weight, carry chlorophyll, carotenoids (β-carotene, zeaxanthin), non-heme iron, and trace minerals; spirulina is the only meaningful dietary source of phycocyanin. Typical dosing in trials: spirulina 1–8 g/day, chlorella 3–10 g/day, often for 6–12 weeks. Claimed effects span (a) lipid markers — total cholesterol, LDL, triglycerides; (b) blood pressure; (c) iron status in iron-deficient adults and pregnancy; (d) antioxidant biomarkers; (e) provision of protein, B-vitamins, and B12. Sourcing matters: both bioaccumulate heavy metals and (for spirulina) cyanotoxins from contaminated water, so contamination is a substance-level, not incidental, consideration USP 2011, Roy-Lachapelle et al. 2017, Di Santis et al. 2024.

Evidence by addressing question

mechanism

Spirulina's hypolipidemic and antihypertensive effects are most often attributed to phycocyanin (the blue chromoprotein, ~10–20% of dry mass) and its chromophore phycocyanobilin, a structural analogue of biliverdin that inhibits NADPH oxidase and reduces vascular ROS, plausibly underpinning small but reproducible blood-pressure reductions Machowiec et al. 2021, Karkos et al. 2011. Phycocyanin and γ-linolenic acid have been proposed as the active lipid-lowering fraction, with rodent work showing inhibition of jejunal cholesterol absorption and reduced hepatic lipogenesis; human dose-response is consistent with these effects but mechanism in humans remains inferential DiNicolantonio et al. 2020. Chlorella's mechanism is less unified: its rigid cellulose cell wall (broken in commercial preparations to permit absorption) carries chlorella growth factor (CGF, a nucleotide-peptide complex), and the intact algae supplies chlorophyll, carotenoids, omega-3 lipids, and methylcobalamin Bito et al. 2020, Kumudha et al. 2015. The cell wall itself binds dioxins and methylmercury in animal models, accelerating fecal excretion — a tentative chelation mechanism not yet established in humans Uchikawa et al. 2010. For iron: both algae supply non-heme iron at roughly 28–60 mg per 100 g; spirulina iron has shown ~6% bioavailability in some studies (a similar range to plant iron generally), reflected in modest hemoglobin rises in deficient cohorts Selmi et al. 2011. The often-claimed B12 mechanism fails for spirulina: ~83% of its cobamide content is pseudovitamin B12 (an inactive analogue that does not bind human intrinsic factor), so spirulina raises measured "B12" on assays without correcting B12 deficiency Watanabe et al. 1999, Watanabe 2007. Chlorella, by contrast, has been shown to contain methylcobalamin, the bioactive form, at small but real quantities (≈0.05–0.07 µg/g) Kumudha et al. 2015, Bito et al. 2020.

evidence

Lipids. Serban and colleagues' 2016 meta-analysis pooled seven RCTs (n=522) of spirulina at 1–10 g/day for 2–12 months and reported significant reductions in total cholesterol (weighted mean difference −46.8 mg/dL), LDL (−41.3 mg/dL), and triglycerides (−44.2 mg/dL), with a smaller HDL rise (+6.1 mg/dL) Serban et al. 2016. The effect sizes are large but the constituent trials are small and heterogeneous (baseline lipids varied widely, some cohorts had NAFLD or T2D, some were healthy adults). The Mazokopakis pilot in NAFLD patients (n=37, 6 g/day for 6 months) showed total cholesterol −16% and LDL −10% from baseline, with ALT/AST reductions Mazokopakis et al. 2014. Parikh's earlier 2-month trial in T2D (n=25, 2 g/day) found LDL −10% and TG −15% Parikh et al. 2001. For chlorella, Fallah's 2018 meta-analysis (19 RCTs, n=797) found significant pooled reductions in total cholesterol, LDL, triglycerides, fasting glucose, systolic BP, and diastolic BP, again with high heterogeneity (I² >60% for several outcomes) and dominance of small trials Fallah et al. 2018. Ryu's 8-week chlorella trial (n=63, 5 g/day) in mildly hypercholesterolemic Korean adults showed total cholesterol −1.6% (NS) but LDL apoB ratio reduction and a rise in lutein/zeaxanthin Ryu et al. 2014. Panahi's RCT in NAFLD (n=70, 1.2 g chlorella/day plus vitamin E for 8 weeks) showed reductions in weight, fasting glucose, ALT, AST, and total cholesterol vs control Panahi et al. 2016. Bottom line: direction of effect is consistent across two independent algae, two independent meta-analyses, and multiple endpoints; absolute magnitudes are inflated by small-trial bias, and a credible everyday effect is probably half to a third of the headline meta-analytic numbers.

Blood pressure. Machowiec's 2021 meta-analysis of five RCTs (n=230) of spirulina 1–8 g/day for 2–12 weeks reported a weighted mean reduction of systolic BP −4.6 mmHg (95% CI −8.6, −0.6) and diastolic BP −7.0 mmHg (95% CI −10.4, −3.7) Machowiec et al. 2021. The DBP estimate is implausibly large for a supplement at typical doses and reflects extreme heterogeneity; SBP effect is on the order of a moderate dietary intervention. Chlorella's Fallah meta found smaller SBP/DBP effects of similar direction Fallah et al. 2018.

Iron status. Selmi's 2011 12-week open-label trial in 40 anemic Mexican seniors (3 g/day spirulina) showed hemoglobin increased by ~1.2 g/dL with corresponding MCV/MCH rises; the trial was uncontrolled and confounded by other dietary factors, but the direction is consistent with iron-and-cofactor provision Selmi et al. 2011. Nakano's 12-week chlorella trial in 70 Japanese pregnant women (6 g/day from week 12) found significantly lower incidence of pregnancy anemia, proteinuria, and edema vs unsupplemented controls Nakano et al. 2010. These are the strongest "felt effect" datapoints; both refer to deficient populations.

Antioxidant markers. Multiple small trials report increases in superoxide dismutase, glutathione peroxidase, and reductions in malondialdehyde (MDA) with spirulina at 4–8 g/day over 4–12 weeks Karkos et al. 2011. These are biomarker shifts; their translation into clinical endpoints is unproven.

B12 specifically. Watanabe's analytic chemistry shows ~83% of spirulina cobalamins are pseudo-B12 (corrinoids that cannot serve as cofactors for human methionine synthase or L-methylmalonyl-CoA mutase) — case reports document apparent B12 deficiency in vegans relying on spirulina Watanabe et al. 1999, Watanabe 2007. Chlorella by contrast contains true methylcobalamin and has been shown in one Japanese open-label trial to raise serum B12 and lower homocysteine in vegan/vegetarian patients with B12 deficiency Bito et al. 2020, Kumudha et al. 2015. The chlorella evidence is preliminary but mechanistically credible; the spirulina-as-B12-source claim is, as a default, wrong.

protocol

Conventional dosing across the trial literature: spirulina 1–8 g/day in divided doses with meals; chlorella 3–10 g/day, often as broken-cell-wall tablets to permit absorption (intact cellulose cell wall is poorly digestible). Tablet weight is typically 250–500 mg, so 6 g/day = ~12–24 tablets. Most trials run 6–12 weeks before lipid endpoints are measured. No commonly used loading dose. Onset for biomarker effects: detectable lipid shifts at 4–8 weeks; iron-status responses in deficient populations at 6–12 weeks. The Mazokopakis NAFLD protocol (6 g/day spirulina × 6 months) and the Nakano pregnancy protocol (6 g/day chlorella) represent the upper-typical end Mazokopakis et al. 2014, Nakano et al. 2010. Iron from these foods absorbs better in the presence of vitamin C and away from tea/coffee, per general non-heme iron handling.

contraindications

Autoimmune disease — spirulina has documented immunostimulant effects (Th1 cytokine elevation); case reports describe flares in lupus, dermatomyositis, multiple sclerosis, and pemphigus vulgaris attributed to spirulina USP 2011, Karkos et al. 2011. The USP safety review concluded spirulina was "Class A" (low risk) for the general population but flagged autoimmune disease as a relative contraindication. Phenylketonuria — spirulina protein contains phenylalanine. Hemochromatosis / iron overload — algal iron loads add to the problem; both species contraindicated. Blood thinners — case reports of bleeding with spirulina plus warfarin; mechanism uncertain (vitamin K content of chlorella also relevant for warfarin INR). Pregnancy — chlorella has positive trial data; spirulina pregnancy data is sparser, but contamination risk (lead, mercury, microcystins) argues for cautious sourcing or avoidance in pregnancy. Cyanotoxin sensitivity / hepatic disease — microcystins from contaminated spirulina are hepatotoxic; ALS and progressive neurologic disease have been epidemiologically linked to BMAA exposure from cyanobacteria, though causality is contested EFSA 2017, Roy-Lachapelle et al. 2017.

misconceptions

Three persistent myths. (1) Spirulina is a vegan B12 source. Not true: it is ~83% pseudovitamin, biologically inactive, and may even compete with real B12 for absorption; serum B12 levels can look normal while functional deficiency progresses Watanabe et al. 1999, Watanabe 2007. Chlorella appears genuinely active but is preliminary evidence; for vegans, cyanocobalamin or methylcobalamin tablets remain first-line. (2) Spirulina is a "complete protein superfood". Spirulina is ~60% protein by dry weight, but at typical 3 g/day supplemental dose this provides ~1.8 g of protein — trivial against a 50–100 g/day requirement. The protein argument only holds at famine-relief doses (10+ g/day), not at supplement doses. (3) Algae "detox" heavy metals. Chlorella shows methylmercury and dioxin chelation in rodents but no robust human RCT confirms accelerated body-burden reduction Uchikawa et al. 2010, Bito et al. 2020. The detox claim is also ironic given that the algae themselves are a common source of heavy-metal exposure when poorly sourced.

practicalities

Cost: ~$15–40/month for a quality 3–6 g/day regimen. Brands with documented third-party heavy-metal and microcystin testing (USP-verified, NSF, Consumer Lab) sit at the higher end; cheap bulk powder from undocumented sources sits at the low end and carries the contamination risk. Geographic provenance correlates with contamination profile: Hawaiian, Japanese, and Indian operations using filtered or distilled water typically test well; Chinese commodity spirulina has shown the highest median lead, arsenic, mercury, and cadmium loads in survey studies Di Santis et al. 2024, Roy-Lachapelle et al. 2017. Practically: powder is cheaper per gram but tastes strongly of pond-water; most users settle on tablets. Algal supplements should be stored cool and away from light to preserve carotenoids and phycocyanin.

failure-modes

Buying contaminated product. A 2017 survey of 18 spirulina and Aphanizomenon supplements in Quebec found microcystins above the WHO tolerable daily intake in 11% of samples and BMAA traces in 95% Roy-Lachapelle et al. 2017; a 2024 systematic review of 87 published heavy-metal screenings of microalgal supplements found ~10–30% of products exceeded EU lead, arsenic, mercury, or cadmium limits, with the worst outliers from unbranded bulk product Di Santis et al. 2024. Treating it as a meal. At supplemental doses it provides micronutrients, not macronutrients; people who substitute it for actual food run macronutrient deficits. Treating spirulina as B12. Documented case-series in vegan diets Watanabe 2007. Stacking with iron supplements when iron status is already adequate. Algal iron is small but additive; in non-deficient adults this is unnecessary, and in those with undiagnosed hemochromatosis it is harmful. Underdosing. Trials showing lipid and BP effects use 2–8 g/day; the 500-mg tablets people often take at 1–2 tablets/day deliver too little to expect biomarker movement.

audience

The cleanest evidence-backed indications are narrow: iron-deficient older adults (spirulina), iron-deficient pregnancy (chlorella, Japanese trial), NAFLD or dyslipidemia adjunct (either, modest effect), and vegans who want a true plant-source B12 hedge (chlorella only — and even there, conventional B12 is more reliable). General "healthy adult takes it daily for wellbeing" is the largest user group in practice and the weakest evidence position.

alternatives

For the same endpoints: lipid-lowering with broader evidence — soluble fibre (psyllium 5–10 g/day, oats β-glucan), plant sterols, statins where indicated. Blood pressure — DASH-style diet, beetroot/dietary nitrate, potassium intake, exercise. Iron — heme iron from meat is ~3–5× more bioavailable; non-heme iron with vitamin C is the vegetarian standard; iron-bisglycinate tablets are tolerated better than ferrous sulfate. B12 — cyanocobalamin or methylcobalamin tablets, fortified foods. Antioxidant biomarker shifts comparable to spirulina are seen with curcumin, green tea catechins, anthocyanin-rich berries; whether any of these translate to clinical benefit remains the same open question.

stakes

Honest framing: the absence of microalgal supplementation in a normal-eating adult costs them very little. Stakes are real only in the specific deficiency cases above (iron-deficient anemia, vegan B12 inadequacy treated naïvely with spirulina rather than a proven source). For the typical healthy reader, the stakes are mostly about buying bad product — heavy-metal exposure from cheap unverified algae is the real downside, not from going without it.

payoff

At supplement doses, in well-sourced product, payoff is biomarker-tier and modest: a few mg/dL off LDL, a few mmHg off systolic BP, a hemoglobin lift if you were deficient, and a subjective "I feel I'm getting something nutritive" effect that varies. The marketed payoffs (energy transformation, detox, immune boost) outrun the evidence; the honest payoffs are real but small.

out-of-scope

Plant-based protein adequacy generally, vegan B12 supplementation specifically, NAFLD as a condition, heme vs non-heme iron handling, cyanotoxin biology and ALS/BMAA hypothesis, broader supplement-industry contamination and the regulatory gap.

The credibility range

Optimist case

Two independent edible microalgae, in two independent meta-analyses, show consistent reductions in total cholesterol, LDL, triglycerides, and blood pressure across heterogeneous trial populations, with plausible bioactive mechanisms — phycocyanin's NADPH-oxidase inhibition, γ-linolenic acid's lipid-modulating effect, the binding of dietary lipids by the chlorella cell wall Serban et al. 2016, Fallah et al. 2018, Machowiec et al. 2021. Iron status improves in deficient cohorts. Chlorella provides genuine methylcobalamin. The biomarker package taken together — lipid, BP, glucose, antioxidant — is exactly the cluster a credible adjunct to diet would shift. At a few dollars a month for a verified product, the risk/benefit case is solidly positive for adults with cardiometabolic risk factors.

Skeptic case

The trial base is small (median trial n < 50), the meta-analyses are dominated by small low-quality RCTs with high heterogeneity (I² 60–90% for many outcomes), and publication bias is plausible. Headline effect sizes (LDL −41 mg/dL for spirulina, DBP −7 mmHg) are too large to be true at typical doses — they implicate small-trial / responder bias Serban et al. 2016, Machowiec et al. 2021. No large multi-centre trial exists. Mechanistic claims rest on rodent and in vitro work that doesn't always reproduce in humans. The B12 story for spirulina is a documented disinformation point. The contamination data — 10–30% of products over heavy-metal limits, 11% of spirulina over microcystin limits — means real consumers are sometimes getting net-negative exposures, especially in pregnancy and chronic dosing Di Santis et al. 2024, Roy-Lachapelle et al. 2017. Most published trials use research-grade material that the average buyer does not get.

Author's call

Direction of effect is real for lipids and blood pressure, magnitude is honestly modest at typical consumer doses (probably half the meta-analytic estimate after correcting for small-trial bias). Iron benefit in deficient adults and pregnancy is plausible and worth taking seriously where deficiency is documented. The B12-from-spirulina claim is wrong as a default. Heavy-metal and cyanotoxin contamination is a substance-level concern, not a fringe one, and dominates the safety picture for casual consumers. Recommendation: a useful, low-cost, modest-effect adjunct for a narrow set of indications (dyslipidemia adjunct in an interested adult, documented iron deficiency, NAFLD with diet), conditional on sourcing; not a meaningful intervention for a healthy person already eating reasonably well, and explicitly not a B12 source if you are vegan and relying on spirulina alone.

Stakeholder + incentive map

Supplement industry. Microalgae are cheap to grow at scale (Hawaii, China, India, Taiwan) and sell at high markup as "superfoods." Vertical integration: a few large producers (Earthrise, Cyanotech, DIC, Sun Chlorella) supply most of the world's branded product; commodity Chinese production supplies private-label and bulk. The "detox", "complete protein", "immune boost", and "B12" claims are all industry-amplified.
Wellness / vegan media. Spirulina and chlorella have iconic status in plant-based circles; the B12 claim, in particular, is propagated by influencer recipes and supplement guides despite the Watanabe analytic chemistry being settled since 1999.
Regulators. EFSA (Europe) has formal opinions on cyanotoxin contamination of food supplements; the U.S. FDA treats algae as GRAS for the main species but does not police contamination claims under DSHEA. USP has a safety class A rating for spirulina with autoimmune-disease caveats USP 2011.
Academic skeptics. Nutritional research community has been steadily critical of pseudo-B12 claims (Watanabe group, Japan, since the 1990s) and of contamination (Roy-Lachapelle, EFSA reviews).
Aquaculture and food-fortification interests. Spirulina is also marketed as a fortifying ingredient in granola, pasta, snacks, particularly in low-income protein-deficiency contexts — a separate use case from supplement tablets, with stronger humanitarian evidence but different scope.

Population variability

Baseline lipid / BP. The same dose probably produces larger absolute reductions in dyslipidemic and hypertensive adults than in normolipidemic ones; the meta-analytic effect skews toward already-abnormal cohorts. A normolipidemic 30-year-old should not expect the LDL drop a 60-year-old with T2D sees in trials.
Iron status. Deficient adults respond; iron-replete adults probably do not benefit and could overshoot if simultaneously supplementing iron.
Vegan diet. Chlorella plausibly contributes real B12; spirulina does not, and may even worsen functional B12 status. Diet context matters more than for most supplements.
Pregnancy. Chlorella has the Japanese trial data Nakano et al. 2010; spirulina has thinner data and elevated contamination risk for a more vulnerable population.
Autoimmune disease. Spirulina may exacerbate Th1-dominant autoimmunity; chlorella has less reported autoimmune signal but is theoretically similar.
Children. Trial data exists in nutritionally deprived child cohorts (famine-relief context); supplementation in well-nourished children is unstudied at meaningful dose-durations.

Knowledge gaps

No large (n > 500) multi-centre RCT exists for either spirulina or chlorella on hard cardiovascular endpoints. Head-to-head trials of spirulina vs chlorella are essentially absent — they are typically studied separately. Long-term safety (> 12 months) of daily 5+ g/day dosing in healthy adults is unstudied. Dose-response for phycocyanin specifically (rather than whole spirulina) is incomplete. The methylmercury and dioxin chelation seen in chlorella rodent models has not been replicated in a controlled human heavy-metal-exposure cohort. Contamination surveys are dominated by single-country or single-jurisdiction snapshots; no longitudinal product-quality dataset exists. What would change the call: a properly powered 12-month RCT in dyslipidemia with verified-low-contaminant product would either confirm a 5–10% LDL effect (worth recommending as a low-tier adjunct) or null it (close the case). A clean B12 trial of chlorella in vegans against cyanocobalamin would settle the B12 question for chlorella specifically.

Two species, one entry. Spirulina and chlorella get covered together because the practical decision the reader faces (whether to take an edible microalgae supplement, and how to avoid getting contaminated product) is identical, the contamination story is identical, and most users discuss the two in one breath. Splitting would have meant two short entries that re-stated the same sourcing rules.

Brief versus coverage. The input description named lipids, BP, iron, B₁₂, antioxidants, and heavy-metal contamination. All six are covered. B₁₂ is covered in evidence and misconceptions together, because the honest finding is half mechanism (spirulina is the wrong source) and half consumer myth (it's still sold as one).

Hard scoping calls.

Evidence score — landed at 2 rather than 3. Two meta-analyses look like 3-tier evidence on the surface, but median trial n < 50, I² often > 60%, no large multicentre trial, and meta effect sizes (LDL −41 mg/dL, DBP −7 mmHg) are too large to be true at typical doses. The honest call is "real direction, thin trial base".
Pregnancy contraindication — tagged because of contamination risk in spirulina, not because of an active pharmacological concern. Chlorella has positive trial data in pregnancy (Nakano 2010). The article carves out the chlorella-in-pregnancy exception inline rather than leaving the reader with a blanket "don't".
Heavy-metal "detox" claim — handled in misconceptions, not as a separate addressing-section's worth. The rodent evidence is real but the human translation isn't, and the larger story (algae often add heavy-metal exposure) is more useful to the reader.
Dimension scoring — every benefit score landed in the 0–2 band because absolute effect at consumer doses is honestly modest. Resisted the pull to score energy and longevity at 2 on the strength of the iron-deficiency cohort and the lipid/BP biomarker shifts — both are real but population-narrow or surrogate-endpoint, which fits 1 better than 2.

Possible future-link candidates.

A standalone vegan-b12-supplementation entry — the spirulina pseudo-B₁₂ story is the leading edge of a wider topic about why plant-based B₁₂ needs an actual supplement
A psyllium-husk entry — first-line LDL lever for the casual reader, mentioned in alternatives
A dietary-nitrate-beetroot entry — better-evidenced BP lever
A supplement-contamination-and-third-party-testing entry — the broader industry problem this entry only touches on
An iron-deficiency-anemia entry — the population for whom these algae have their sharpest effect

Separate-entry candidates.

Phycocyanin as a standalone supplement — purified phycocyanin is starting to be sold separately and has its own (small) trial base; worth its own entry if the volume warrants
BMAA / cyanotoxins and chronic neurologic risk — too speculative to fit in this entry's evidence frame, but the ALS-cluster epidemiology is real enough to deserve standalone treatment

Dream tier. Computed overall score ~17 (well below 40). Wrote a short relief-lever dream narrative anyway — the "stop being marketed at" hook genuinely sharpens the tagline and dek without inflating the article body. Dek lifted the eighty-twenty framing from the narrative directly; tagline crystallised the contamination-over-dose insight.